|
MechanismVCAM1 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Toyobo (Shanghai) Biotech Co. Ltd.
0 Patents (Medical) associated with Toyobo (Shanghai) Biotech Co. Ltd.
100 Deals associated with Toyobo (Shanghai) Biotech Co. Ltd.
100 Translational Medicine associated with Toyobo (Shanghai) Biotech Co. Ltd.